The UK standards for Paediatric Endocrinology are below, followed by other guidelines and standards sorted into endocrine and diabetes.
Each patient should be considered as an individual in the context of their condition and other medication and therefore the readers' discretion is required in the application of their use of these guidelines and standards. Every effort has been made to ensure the factual accuracy of the contents but no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines and standards.
If you have a query or comment, or would like to raise a concern about any document on this page, please contact the BSPED Office who will ensure your message is passed to the BSPED Clinical Guidelines Officer and Clinical Committee.
Included on this page are:
BSPED Guidelines and Standards (guidelines produced for the BSPED): Commissioned and developed by BSPED and reflect the Society's views on best practice for the majority of patients with that condition.
BSPED Endorsed Guidelines and Standards: Produced by accredited national bodies (e.g. NICE, RCPCH, ACDC) of which BSPED are stakeholders. BSPED may have been involved in the development, but are not the original authors.
Local Guidelines: The BSPED has not been involved in the development of these guidelines and takes no responsibility for the content. Please note local guidelines may vary between trusts.
For BSPED endorsement of a guideline or standard please review the BSPED Clinical Guideline/Standard Endorsement Process. Authors of guidelines/standards are required to sign the BSPED Declaration of Interest form (definitions of conflicting interests are listed on the form).
UK standards for Paediatric Endocrinology
The UK standards for Paediatric Endocrinology were initially published in 2019 and have been updated in 2024 by the BSPED. They are endorsed by the Royal College of Paediatrics and Child Health. The standards apply to all children and young people aged 0-18 years with an endocrine condition. The aims of the standards are to reduce variability in care and to ensure that equitable services providing high quality, safe and effective care are available to all children and families across the UK. The standards are intended for healthcare professionals and for service commissioners to plan, deliver and quality assure paediatric endocrine services. Review date: January 2029.
targetSection: Guidelines Repository
Category | Guideline | Type | Source | Date of document | Review date |
Adrenal Insufficiency | BSPED | BSPED | Nov 2022 | Nov 2028 | |
Bone | Endorsed | DMD Care UK | Oct 2023 | Oct 2026 | |
Bone | Endorsed | DMD Care UK | March 2025 | March 2028 | |
DSD | Endorsed | Society for Endocrinology | April 2021 | May 2026 | |
DSD | BSPED | BSPED | Nov 2017 | June 2026 | |
Growth | BSPED | BSPED SIG | Oct 2025 | Oct 2028 | |
Growth | Endorsed | BMJ | Dec 2025 | Dec 2028 | |
Growth | BSPED | BSPED | Nov 2025 | Nov 2028 | |
Growth | Shared care guidelines: Paediatric use of Recombinant Human Growth Hormone (r-hGH) | BSPED | BSPED | Dec 2023 | Jan 2027 |
Growth | Recommendations for Recombinant IGF-1 therapy in Children with severe insulen resistent Syndromes | BSPED | BSPED SIG | May 2024 Revision: Dec 2025 | May 2027 |
Growth | BSPED | BSPED SIG | Dec 2023 Revision: Dec 2025 | April 2027 | |
Growth | Endorsed | BSPED/BAPN/PRING | March 2024 | March 2027 | |
Growth | BSPED | BSPED SIG | Nov 2022 | Nov 2026 | |
Growth | Clinical Standards For GH Treatment Of Growth Disorders Excluding GHD 2026 | BSPED | BSPED SIG | Dec 2023 | Dec 2026 |
Growth | Clinical Standards for GH treatment of GH deficiency (GHD) | BSPED | BSPED SIG | Aug 2022 | Aug 2027 |
Growth | Guidance for use of aromatase inhibitors (AI) to optimise linear growth and preserve final height | BSPED | BSPED SIG | Jan 2026 | Jan 2029 |
Growth | BSPED | BSPED SIG | Jan 2026 | Jan 2029 | |
Puberty / Gonads | BSPED | BSPED | Sept 2025 | Sept 2028 | |
Puberty / Gonads | BSPED | BSPED | Aug 2024 | Aug 2027 | |
Puberty / Gonads | Shared care guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists | BSPED | BSPED | Sept 2025 | Sept 2028 |
Puberty / Gonads | GnRH Analogue Stimulation Testing to Investigate Precocious Puberty | BSPED | BSPED | Jul 2021 Revision: Apr 26 | Apr 2029 |
Oncology | Endorsed | CCLG | 2021 | 2026 | |
Oncology | Endorsed | CCLG | 2021 | 2026 | |
Oncology | CCLG: Paediatric Differentiated Thyroid Carcinoma: UK National Clinical Practice Consensus Guideline | Endorsed | CCLG | 2021 | 2026 |
Turner Syndrome | Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome | Endorsed | ESPE/International Consensus | 2024 | 2028 |
Local/ Other Endocrine Guidelines and Useful Resources
These guidelines are local/other endocrine guidelines which have been made available to BSPED members. The BSPED have not been involved in the development of these guidelines and take no responsibility for the content. Please note local guidelines may vary between Trusts.
If a local trust wishes to publish their guidelines on the BSPED website, please email the BSPED Office ([email protected]) and we will put you in touch with our Clinical Guidelines Officer.
Category | Guideline | Type | Source | Date of document |
Adrenal | The Investigation of suspected Paediatric Cushing’s Syndrome | Supported | Barts and the London School of Medicine | April 2021 |
Puberty/Gonads | Supported | QMUL/Barts/UCLH/Alder Hey | May 2025 | |
Thyroid | Supported | British Thyroid Association Guideline management of Paediatric Graves disease | 2022 | |
Hyperinsulinism | Supported | UK national consensus | 2023 | |
Prader-Willi Syndrome | Prader–Willi syndrome: guidance for children and transition into adulthood | Supported | PWS Network consensus group | July 2024 |
Guideline | Type | Source | Date of document /last updated | Review date |
BSPED | BSPED | See DKA Guidelines page | Nov 2024 | |
Diabetes (type 1 and type 2) in children and young people: diagnosis and maagement | Endorsed | NICE | Dec 2020 | May 2023 |
Endorsed | BAPM | Sept 2025 | Sep 2028 |
ACDC Endorsed Diabetes Guidelines
Please refer to the ACDC website for Endorsed Guidelines for the most up to date diabetes guidelines listed below.
Guideline | Type | Source |
Executive summary - A Practical Approach to the Management of Type 2 Diabetes in children and young people under 18yrs | Endorsed | ACDC/BSPED |
Care of the Well Child-Newly Diagnosed with Type 1 Diabetes | Endorsed | ACDC/BSPED |
Sick day guideline executive summary v4 | Endorsed | ACDC/BSPED |
Sick day guideline Main V4 | Endorsed | ACDC/BSPED |
Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes | Endorsed | ACDC/BSPED |
A Practical Approach to the Self Management of Diabetes As An Inpatient for Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
A Practical Approach to the Management of Steroid, Chemotherapy or Transplant Induced Hyperglycaemia or Diabetes in Children and Young People Under 18 years in the Acute or Inpatient Setting | Endorsed | ACDC/BSPED |
Dexcom G4 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Dexcom G5 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Dexcom G6 CGM Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Medtronic 640G Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Libre FGS Training Leaflet for Healthcare Professionals and Patients | Endorsed | ACDC/BSPED |
Care of children under 18 years with Diabetes Mellitus undergoing Surgery - currently being updated | Endorsed | ACDC/BSPED |
Executive Summary: A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years | Endorsed | ACDC/BSPED |
Practical Management of Hyperglycaemic Hyperosmolar State (HHS) in children | Endorsed | ACDC/BSPED |
Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |
Executive Summary- Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |
Patient Advice for Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) | Endorsed | ACDC/BSPED |